title: Delayed profound thrombocytopenia presenting 7 days after use of abciximab (ReoPro).
abstract: A case of a 65-year-old woman presenting with delayed profound thrombocytopenia 7 days after the use of abciximab (ReoPro) in the setting of percutaneous coronary intervention is described. The patient had normal platelet counts for the first 24 hours after the use of abciximab (ReoPro). She presented with petechiae and profound thrombocytopenia 1 week later. The patient was treated successfully with a platelet transfusion and recovered uneventfully. Profound thrombocytopenia occurs acutely within the first few hours after abciximab (ReoPro) use, so this case was unique in that the profound thrombocytopenia presented 1 week after use of abciximab (ReoPro).
authors: Central Cardiology Medical Clinic and Bakersfield Heart Hospital, 2110 Truxtun Avenue, Bakersfield, CA 93301, USA.
authors: Sanjiv
authors: S
authors: Sharma
authors: Brijesh
authors: B
authors: Bhambi
authors: William
authors: W
authors: Nyitray
authors: Geetanjali
authors: G
authors: Sharma
authors: Shawn
authors: S
authors: Shambaugh
authors: Adrian
authors: A
authors: Antonescu
authors: Pankaj
authors: P
authors: Shukla
authors: Eileen
authors: E
authors: Denny
mesh_terms: D000077284:Abciximab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects* / Q000627:therapeutic use; D017713:Platelet Transfusion; D011693:Purpura / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced*; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab